Balstilimab (PDCD1/PD1/CD279) - Research Grade Biosimilar
Product Specifications
Background
PD-1 monoclonal antibody balstilimab is used to treat cervical cancer, balstilimab monotherapy and anti-CTLA-4 monoclonal antibody zalifrelimab combined with balstilimab for metastatic cervical cancer.
Immunogen
Homo sapiens / PDCD1/PD1/CD279 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer, Immunology
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
AGEN2034
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1603204 1.0 µg DNA
PCDH20 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details orb3143209-01 10 mg
FA2[3]G1 & FA2[6]G1 glycan (G1F), APTS labelled
Sign In for Pricing
View Details